Searchable abstracts of presentations at key conferences in endocrinology

ea0028p269 | Pituitary | SFEBES2012

A case report of hypopituitarism following recovery from cardiac arrest - a poorly recognised sequelae?

Joseph Stonny , Fenton Mark , Kearney Edward

Hypopituitarism is a recognised complication of pituitary and hypothalamic pathology. It can also be a consequence, less commonly, of traumatic brain injury. It has never been described in patients following recovery from a cardiac arrest. We present a case history of hypopituitarism following successful cardiopulmonary resuscitation for a ventricular tachycardia (VT) cardiac arrest. A 51 year old patient with known prolonged QT (Romano ward) syndrome and chronic obstructive a...

ea0077p60 | Metabolism, Obesity and Diabetes | SFEBES2021

Mimicking chronic hyperglycaemic conditions in primary human endothelial cell cultures using pathophysiological concentrations of glucose in prediabetes and type 2 diabetes

Luk Cheukyau , Haywood Natalie J , Kearney Mark T

Introduction: In the UK alone, diabetes affects nearly 4 million people and an additional 13.6 million people are estimated to be at high risk of developing type 2 diabetes (T2DM). Diabetes is associated with vascular complications which path the development of cardiovascular diseases such as strokes and heart attacks. Previous studies have shown various pathways in which hyperglycaemia leads to endothelial dysfunction and insulin resistance. However, current reports of <e...

ea0086p210 | Metabolism, Obesity and Diabetes | SFEBES2022

Elucidating endothelial-derived molecules with potential anti-obesity properties via crosstalk with enterocytes and gut microbiota

Luk Cheukyau , Haywood Natalie J , Cubbon Richard , Kearney Mark T

Introduction: Overweight and obesity is a worldwide chronic disease affecting 2 billion adults and millions of children. In diet-induced obesity (DIO), current treatments are not always effective or suitable for all patients due to the complexity of obesity and its associated health complications. Recently, the potential of developing weight loss therapy by targeting the gut microbiota has been raised. Previously, we have shown that mice overexpressing insulin-like growth fact...

ea0086p56 | Metabolism, Obesity and Diabetes | SFEBES2022

Macrophage-specific SHIP2 knockdown mice display sex-dependent liver steatosis

Chabrier Gwladys , Pineda-Torra Ines , Yuldasheva Nadira , Kearney Mark , Gage Matthew

Background: Non-alcoholic fatty liver disease (NAFLD) is a spectrum of progressive liver diseases driven in part by macrophages, occurring in the absence of excessive alcohol consumption that ranges from simple steatosis to non-alcoholic steato-hepatitis (NASH), ultimately progressing to fibrosis/cirrhosis and hepatocellular carcinoma. NAFLD is associated with insulin resistance and confers an increased risk of cardiovascular disease. Pre-menopausal women are protected against...

ea0021oc1.1 | Diabetes and metabolism | SFEBES2009

IGF1 receptor and insulin receptor stoichiometry is a critical determinant of nitric oxide bioavailablity

Abbas Afroze , Viswambharan Hema , Imrie Helen , Rajwani Adil , Wheatcroft Stephen , Grant Peter , Kearney Mark

Introduction: Accumulating evidence suggests a role for IGF1 in insulin resistance and cardiovascular disease. IGF1 enhances glucose uptake and nitric oxide (NO) production, via similar mechanisms to insulin. Previously we have reported a mouse model with global heterozygous knockout of the IGF1 receptor (IGF1RKO) that has enhanced insulin sensitivity and increased nitric oxide (NO) production in the vasculature.Methods: To investigate this further we us...

ea0094op2.1 | Metabolism, Obesity and Diabetes | SFEBES2023

Insulin resistance in macrophages impacts cholesterol biosynthesis and interferon gene expression and reduces foam cell formation capacity

Chabrier Gwladys , Pineda-Torra Ines , Hobson Sam , Yuldasheva Nadira , Kearney Mark , Schurmans Stephane , Gage Matthew

Background: Insulin resistance and ageing are risk factors for the development of type 2 diabetes and atherosclerosis. Insulin signalling in macrophages affects their inflammatory responses and foam cell formation capacity, yet the mechanisms linking these remain unclear. Recent evidence has emerged linking macrophage lipid metabolism and inflammatory response such as an interferon-cholesterol pathway flux axis. Insulin has been shown to directly regulate chol...

ea0050p205 | Diabetes and Cardiovascular | SFEBES2017

The effect of escalating doses of beta-blockers and ACE inhibitors on mortality in patients with heart failure and diabetes mellitus

Kearney Jessica , Walker Andrew , Patel Peysh , Drozd Michael , Witte Klaus , Slater Thomas , Kearney Lorraine , Kearney Mark , Cubbon Richard

Introduction: Diabetes mellitus (DM) is a common co-morbidity in patients with heart failure and reduced left ventricular ejection fraction (HF-REF), and is associated with adverse prognosis. Subgroup analyses of randomized controlled trials suggest patients with DM benefit prognostically from beta-adrenoreceptor blockers (BB) and angiotensin converting enzyme inhibitors (ACEi). However, it remains unclear whether escalating doses of these age...

ea0050p205 | Diabetes and Cardiovascular | SFEBES2017

The effect of escalating doses of beta-blockers and ACE inhibitors on mortality in patients with heart failure and diabetes mellitus

Kearney Jessica , Walker Andrew , Patel Peysh , Drozd Michael , Witte Klaus , Slater Thomas , Kearney Lorraine , Kearney Mark , Cubbon Richard

Introduction: Diabetes mellitus (DM) is a common co-morbidity in patients with heart failure and reduced left ventricular ejection fraction (HF-REF), and is associated with adverse prognosis. Subgroup analyses of randomized controlled trials suggest patients with DM benefit prognostically from beta-adrenoreceptor blockers (BB) and angiotensin converting enzyme inhibitors (ACEi). However, it remains unclear whether escalating doses of these age...

ea0086p213 | Metabolism, Obesity and Diabetes | SFEBES2022

Differentially expressed genes in insulin resistant macrophages are shared across multiple diabetes associated morbidities

Goodhew Katie , Grammatopoulos Kyriakos , Jackson Amy , Makahamadze Ayanteh , Pineda-Torra Ines , Yuldasheva Nadira , Kearney Mark , Gage Matthew

Authors 1-4 contributed equally to this work.Background: Insulin resistance is the central defining feature of type 2 diabetes and increases with age. People with type 2 diabetes are at an increased risk of cardiovascular disease, non-alcoholic fatty liver disease (NAFLD), Alzheimer’s disease and arthritis. Macrophages are phagocytotic leukocytes which play a central role in the development of type 2 diabetes and the chronic inflammatory di...

ea0015p149 | Diabetes, metabolism and cardiovascular | SFEBES2008

Metabolic and vascular IGF-1 resistance is a marker of dietary-induced obesity

Imrie Helen , Viswambharan Hema , Rajwani Adil , Abbas Afroze , Cubbon Richard , Kahn Matthew , Gayle Chris , Wheatcroft Stephen , Kearney Mark

Endothelial dysfunction is a key step in the initiation of atherosclerosis, resulting from a decrease in bioavailability of nitric oxide (NO). IGF-1 may play a part in regulation of NO production via the PI3-kinase/Akt/eNOS pathway. We have investigated whether disturbances of this pathway occur in dietary-induced obesity.Obesity was induced in mice fed a high fat diet for 20 weeks (n=12), compared to chow fed controls, with an age-related increas...